| Literature DB >> 29921221 |
Seongwon Cha1, Ji Eun Lim2, Ah Yeon Park3, Jun-Hyeong Do1, Si Woo Lee1, Chol Shin4, Nam Han Cho5, Ji-One Kang2, Jeong Min Nam2, Jong-Sik Kim6, Kwang-Man Woo6, Seung-Hwan Lee6, Jong Yeol Kim7, Bermseok Oh8.
Abstract
BACKGROUND: Face morphology is strongly determined by genetic factors. However, only a small number of genes related to face morphology have been identified to date. Here, we performed a two-stage genome-wide association study (GWAS) of 85 face morphological traits in 7569 Koreans (5643 in the discovery set and 1926 in the replication set).Entities:
Keywords: DHX35; Face morphology; GWAS; HOXD1-MTX2; Korean; OSR1-WDR35; SOX9; WDR27
Mesh:
Substances:
Year: 2018 PMID: 29921221 PMCID: PMC6008943 DOI: 10.1186/s12864-018-4865-9
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Eighty-five facial traits from 23 frontal, 7 profile, and 16 upper eyelid points
| Size-related variables | Shape-related variables | ||||
|---|---|---|---|---|---|
| Abbreviation | Description | Abbreviation | Description | ||
| Face shape | (17 traits) | ||||
| Widtha | zyR-zyL | Facial base width | Ratio | zyR-zyL/goR -goL | Facial width ratio of base to chin |
| goR -goL | Lower facial width | zyR-zyL/n-sto | Facial ratio of base width to height | ||
| obsR-obsL | Upper facial width | goR -goL/n-sto | Facial ratio of chin width to height | ||
| obiR-obiL | Middle facial width | ||||
| Heightb | sn-sto | Upper lip height | Anglec | (A) enR-exR-goR | Right facial angle of en-ex-go |
| n-sto | Facial height | (A) enL-exL-goL | Left facial angle of en-ex-go | ||
| Area | (AR) obsR-obsL-obiR-obiL | Upper facial area | (A) psR-exR-goR | Right facial angle of ps-ex-go | |
| (AR) obiR-obiL-goR -goL | Lower facial area | (A) psL-exL-goL | Left facial angle of ps-ex-go | ||
| (A) enR-psR-goR | Right facial angle of en-ps-go | ||||
| (A) enL-psL-goL | Left facial angle of en-ps-go | ||||
| Forehead | (10 traits) | ||||
| Heightb | (V) tr-o | Forehead height | Anglec | (A) m-tr | Upper forehead slant angle |
| (V) m-o | Lower forehead height | (A) o-n | Brow ridge protrusion angle | ||
| (V) tr-m | Upper forehead height | Ratio | mtro-o/t-o | Metopion position ratio | |
| (V) o-n | Brow ridge height | Depth | (H) tr-m | Upper forehead slant depth | |
| (H) o-n | Brow ridge protrusion | ||||
| m-mtro | Metopion eminence depth | ||||
| Eye | (15 traits) | ||||
| Widtha | enR-enL | Intercanthal width | Anglec | (A) exR-psR | Right eye angle of ex-ps |
| exR-exL | Outercanthal width | (A) exL-psL | Left eye angle of ex-ps | ||
| (A) enR-psR | Right eye angle of en-ps | ||||
| (A) enL-psL | Left eye angle of en-ps | ||||
| Heightb | psR-piR | Right palpebral fissure height | (A) enR-psR-exR | Right eye angle of en-ps-ex | |
| psL-piL | Left palpebral fissure height | (A) enL-psL-exL | Left eye angle of en-ps-ex | ||
| Length | enR-exR | Right palpebral fissure length | Length | psR-exR | Eye tail length |
| enL-exL | Left palpebral fissure length | Ratio | psR-piR/enR-exR | Eye ratio of width to height | |
| (enR-exR + enL-exL)/zyR-zyL | Length ratio of eyes to face | ||||
| Nose | (11 traits) | ||||
| Widtha | sbalR-sbalL | Subnasal width | Anglec | (A) prn-n | Nasal bridge angle |
| Heightb | (V) n -sn | Frontal nasal height | (A) prn-sn | Nasolabial angle | |
| n-sn | Profile nasal length | (A) n-prn-sn | Profile nasal angle | ||
| (V) n-prn | Nasal bridge height | ||||
| (V) prn-sn | Nasal tip height | ||||
| Depth | (H) n-prn | Nasal bridge depth | |||
| (H) prn-sn | Nasal tip protrusion | ||||
| Area | (AR) n-prn-sn | Profile nasal area | |||
| Mouth | (2 traits) | ||||
| Heightb | (V) cphR-sto | Right upper lip thickness | |||
| (V) cphL-sto | Left upper lip thickness | ||||
| Upper eyelid | (30 traits) | ||||
| Widtha | (H) er1-ermax | Right eyelid peak width | Anglec | (A) Tan_er1~ 7 | Tangent line angle of er1 ~ er7 |
| (H) el1-elmax | Left eyelid peak width | (A) Tan_el1~ 7 | Tangent line angle of el1 ~ el7 | ||
| (H) er1-er7 | Right eyelid width | Ratio | (H) er1-ermax/(H) er1-er7 | Right eyelid peak position ratio | |
| (H) el1-el7 | Left eyelid width | (H) el1-elmax/(H) el1-el7 | Left eyelid peak position ratio | ||
| (V) er1-er7/(H) er1-er7 | Right eyelid slant | ||||
| (V) el1-el7/(H) el1-el7 | Left eyelid slant | ||||
| (V) er1-ermax/(H) er1-ermax | Right eyelid medial slant | ||||
| (V) el1-elmax/(H) el1-elmax | Left eyelid medial slant | ||||
| (V) ermax-er7/(H) ermax-er7 | Right eyelid lateral slant | ||||
| (V) elmax- el7/(H) elmax- el7 | Left eyelid lateral slant | ||||
| Curvatured | (AC) er1-er7 | Right eyelid average curvature | |||
| (MC) er1-er7 | Right eyelid maximal curvature | ||||
| (AC) el1-el7 | Left eyelid average curvature | ||||
| (MC) el1-el7 | Left eyelid maximal curvature | ||||
Trait abbreviations: cph crista philtri, el left upper eyelid, elmax left upper eyelid peak, en endocanthion, er right upper eyelid, ermax right upper eyelid peak, ex exocanthion, go gonion, m metopion, mtro metopion position on tr-o, n nasion, o ophryon, obi otobasion inferius, obs otobasion superius, pi palpebral inferius, prn pronasale, ps palpebral superius, sbal subalare, sn subnasale, sto stomion, tr trichion, zy zygion, (A) angle, (AC) average curvature, (AR) area, (H) horizontal, (MC) maximal curvature, (V) vertical
aWidth refers to the horizontal distance between the two landmarks in a frontal (or lateral) image
bHeight similarly refers to the vertical distance between the two landmarks in a frontal (or lateral) image
cAngle refers to the angle made from the line through two landmarks and a horizontal line in a frontal (or lateral) image
dCurvature indicates the radius of circle at a point n1 in a frontal upper eyelid
Fig. 1Facial points used for the facial traits. The participants were photographed in both frontal and profile views, and 23 frontal and seven lateral face points were extracted (modified from Fig. 1 of reference [34]). Facial phenotypes, such as distance, angle, and area, were measured based on in-house facial data acquisition software. a Points in the right eye, b points in the left eye, c points and areas in frontal images, d points in lateral images
Association results of five novel SNPs in Phase 1, Phase 2, and the Phase 1 + 2 meta-analysis
| SNP | CHR:Position(bp)a | Geneb | Coded allele | Non-coded allele | Facial traits | Association results | Meta-analysis (Phase 1 + 2) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AF | beta ± se | beta ± se | Q | I2 | ||||||||||
| rs7567283 | 2:19,595,772 |
| G | A | Right facial angle of en-ex-go | Phase 1 | 0.24 | −0.572 ± 0.109 | 1.72 × 10−7 | − 0.536 ± 0.096 |
| 0.48 | 0.00 | |
| Phase 2 | 0.24 | − 0.410 ± 0.205 | 0.046 | |||||||||||
| rs970797 | 2:176,820,065 |
| A | C | Tangent line angle of el3 | Phase 1 | 0.33 | 0.017 ± 0.003 |
| 0.015 ± 0.003 |
| 0.29 | 12.52 | |
| Phase 2 | 0.34 | 0.011 ± 0.005 | 0.030 | |||||||||||
| Tangent line angle of er3 | Phase 1 | 0.33 | 0.015 ± 0.003 | 4.51 × 10−7 | 0.015 ± 0.003 |
| 0.93 | 0.00 | ||||||
| Phase 2 | 0.34 | 0.014 ± 0.005 | 0.003 | |||||||||||
| rs3736712 | 6:169,699,889 |
| C | T | Eye tail length | Phase 1 | 0.37 | 0.322 ± 0.055 |
| 0.293 ± 0.048 |
| 0.30 | 6.92 | |
| Phase 2 | 0.38 | 0.208 ± 0.095 | 0.029 | |||||||||||
| rs2193054 | 17:67,537,404 |
| C | G | Profile nasal angle | Phase 1 | 0.47 | −0.007 ± 0.001 |
| −0.007 ± 0.001 |
| 0.22 | 33.67 | |
| Phase 2 | 0.46 | −0.009 ± 0.002 | 4.60 × 10− 7 | |||||||||||
| Nasal tip protrusion | Phase 1 | 0.47 | 0.019 ± 0.003 |
| 0.017 ± 0.003 |
| 0.23 | 31.80 | ||||||
| Phase 2 | 0.46 | 0.011 ± 0.005 | 0.050 | |||||||||||
| rs2206437 | 20:37,426,155 |
| A | T | Subnasal width | Phase 1 | 0.26 | −0.272 ± 0.054 | 4.75 × 10− 7 | − 0.283 ± 0.047 |
| 0.69 | 0.00 | |
| Phase 2 | 0.28 | − 0.316 ± 0.095 | 8.67 × 10−4 | |||||||||||
Bold and underlined text indicates genome-wide significant P values (5 × 10−8)
CHR chromosome, AF coded allele frequency, Q P-value for Cochrane’s Q statistic, I heterogeneity index
aPositions according to NCBI Build 36
bGenes are defined as the gene within the SNP locates or genes closest to the SNP within a ±400-kb window when the SNP dose not locate within a gene
Fig. 2Regional association plots for five novel loci across a 1-Mb window. Association of individual SNPs in the discovery GWAS plotted as −log10(P) against the chromosomal base-pair position. The y-axis on the right shows the recombination rate, estimated from the HapMap CHB and JPT populations. P-values are from the discovery phase. The purple circle and diamond represent the results of discovery and meta-analysis (Phase 1 + 2), respectively. Seven signal plots for five novel SNPs are illustrated, which show the genome-wide significant P-values in the meta-analysis (Phase 1 + 2). a rs7567283 of the right facial angle of en-ex-go [(A) enR-exR-goR], b rs970797 of the tangent line angle of er3 [(A) Tan_er3], c rs970797 of the tangent line angle of el3 [(A) Tan_el3], d rs3736712 of eye tail length (psR-exR), e rs2193054 of profile nasal angle [(A) n-prn-sn], f rs2193054 of nasal tip protrusion [(H) prn-sn], and g rs2206437 of subnasal width (sbalR-sbalL)
Fig. 3Associated facial traits for five novel SNPs. Five novel SNPs and the associated facial traits are illustrated on the frontal, lateral, and eye images. (1) rs7567283 (OSR1-WDR35) and right facial angle, (2) rs970797 (HOXD1-MTX2) and left and right curvature of the upper eyelid, (3) rs3736712 (WDR27) and eye tail length, (4) rs2193054 (SOX9) and nose shape (angle and height), and (5) rs2206437 (DHX35) and subnasal width
Fig. 4Association signals in the SOX9 locus and genomic environment surrounding SOX9 across a 4-Mb window. The upper five panels present multiple signals, (1) rs9915190, (2) rs1859979, (3) rs9910003, and (4) rs2193054, in the SOX9 locus for five nose traits: nasal tip protrusion [(H) prn-sn], nasal bridge depth [(H) n-prn], profile nasal area [(AR) n-prn-sn], nasolabial angle [(A) prn-sn], and profile nasal angle [(A) n-prn-sn]. These are plotted as −log10(P) against base-pair position on chromosome 17 (Mb) and all P-values are from the discovery phase. The sixth panel shows genes and regulatory domains. Gray boxes represent approximate boundaries of translocation breakpoint clusters, and black boxes represent microdeletions. (a) Sp4 [31], (b) F1 [31], (c) Pierre Robin sequence (PRS) breakpoint cluster [31, 32], (d) distal breakpoint cluster [30], (e) proximal breakpoint cluster [30], and (f) Sp2 [31]. The last panel presents LD blocks based on the HapMap database (HapMap Phase II JPT + CHB, hg18)
Association results of SNPs within the SOX9 locus (5643 discovery GWAS participants and 1940 SOX9 replication participants)
| SNP | CHR:Position (bp)a | Distance from 5′ of SOX9 | Coded allele (AF) | Non-coded allele | Nose Traits | Association results | Meta-analysis (Phase 1 + | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| beta ± se | beta ± se | Q | I2 | ||||||||||
| rs9915190 | 7:66,654,223 | 974 kb | A(0.45) | C | Nasal tip protrusion | Phase 1 | −0.015 ± 0.003 | 6.03 × 10−6 | − 0.016 ± 0.003 |
| 0.72 | 0.00 | |
| Phase 1 (3 SNPs conditional) | −0.016 ± 0.003 | 2.08 × 10− 6 | |||||||||||
| − 0.017 ± 0.004 | 7.04 × 10− 5 | ||||||||||||
| Nasal bridge depth | Phase 1 | − 0.198 ± 0.063 | 1.68 × 10−3 | − 0.112 ± 0.052 | 3.05 × 10− 2 | 0.02 | 82.56 | ||||||
| Phase 1 (3 SNPs conditional) | −0.204 ± 0.063 | 1.22 × 10− 3 | |||||||||||
| 0.066 ± 0.091 | 4.65 × 10−1 | ||||||||||||
| Profile nasal area | Phase 1 | − 0.017 ± 0.003 | 3.10 × 10− 7 | − 0.016 ± 0.003 |
| 0.61 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | − 0.017 ± 0.003 | 1.26 × 10− 7 | |||||||||||
| −0.014 ± 0.005 | 1.91 × 10− 3 | ||||||||||||
| Nasolabial angle | Phase 1 | 0.007 ± 0.002 | 3.21 × 10− 3 | 0.009 ± 0.002 | 2.68 × 10− 5 | 0.34 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | 0.008 ± 0.002 | 1.69 × 10− 3 | |||||||||||
| 0.011 ± 0.004 | 1.73 × 10− 3 | ||||||||||||
| Profile nasal angle | Phase 1 | 0.005 ± 0.001 | 5.79 × 10− 6 | 0.004 ± 0.001 | 4.07 × 10− 7 | 0.47 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | 0.005 ± 0.001 | 1.02 × 10− 6 | |||||||||||
| 0.003 ± 0.001 | 1.83 × 10− 2 | ||||||||||||
| rs1859979 | 7:66,940,738 | 688 kb | C(0.46) | T | Nasal tip protrusion | Phase 1 | 0.018 ± 0.003 | 1.56 × 10− 7 | 0.017 ± 0.003 |
| 0.68 | 0.00 | |
| Phase 1 (3 SNPs conditional) | 0.017 ± 0.003 | 7.50 × 10− 7 | |||||||||||
| 0.016 ± 0.004 | 2.98 × 10− 4 | ||||||||||||
| Nasal bridge depth | Phase 1 | 0.331 ± 0.064 | 2.21 × 10− 7 | 0.272 ± 0.052 | 1.92 × 10− 7 | 0.11 | 61.76 | ||||||
| Phase 1 (3 SNPs conditional) | 0.323 ± 0.064 | 4.76 × 10− 7 | |||||||||||
| 0.152 ± 0.091 | 9.33 × 10− 2 | ||||||||||||
| Profile nasal area | Phase 1 | 0.022 ± 0.003 |
| 0.018 ± 0.003 |
| 0.09 | 64.77 | ||||||
| Phase 1 (3 SNPs conditional) | 0.020 ± 0.003 |
| |||||||||||
| 0.012 ± 0.005 | 6.59 × 10− 3 | ||||||||||||
| Nasolabial angle | Phase 1 | −0.011 ± 0.002 | 9.86 × 10− 6 | − 0.013 ± 0.002 |
| 0.11 | 60.21 | ||||||
| Phase 1 (3 SNPs conditional) | − 0.011 ± 0.002 | 2.10 × 10− 5 | |||||||||||
| −0.018 ± 0.004 | 8.09 × 10− 7 | ||||||||||||
| Profile nasal angle | Phase 1 | − 0.006 ± 0.001 |
| − 0.007 ± 0.001 |
| 0.63 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | − 0.006 ± 0.001 |
| |||||||||||
| − 0.007 ± 0.001 | 8.17 × 10− 7 | ||||||||||||
| rs9910003 | 7:67,390,279 | 238 kb | A(0.28) | G | Nasal tip protrusion | Phase 1 | 0.015 ± 0.004 | 4.05 × 10− 5 | |||||
| Phase 1 (3 SNPs conditional) | 0.007 ± 0.004 | 9.07 × 10− 2 | |||||||||||
| Nasal bridge depth | Phase 1 | 0.038 ± 0.071 | 5.90 × 10− 1 | ||||||||||
| Phase 1 (3 SNPs conditional) | − 0.077 ± 0.079 | 3.33 × 10− 1 | |||||||||||
| Profile nasal area | Phase 1 | 0.007 ± 0.004 | 7.71 × 10− 2 | ||||||||||
| Phase 1 (3 SNPs conditional) | 0.001 ± 0.004 | 8.50 × 10− 1 | |||||||||||
| Nasolabial angle | Phase 1 | −0.011 ± 0.003 | 1.12 × 10− 4 | ||||||||||
| Phase 1 (3 SNPs conditional) | −0.004 ± 0.003 | 1.99 × 10− 1 | |||||||||||
| Profile nasal angle | Phase 1 | −0.004 ± 0.001 | 3.87 × 10− 4 | ||||||||||
| Phase 1 (3 SNPs conditional) | 0.000 ± 0.001 | 8.06 × 10− 1 | |||||||||||
| rs2193054 | 17:67,537,404 | 91 kb | C(0.47) | G | Nasal tip protrusion | Phase 1 | 0.019 ± 0.003 |
| 0.017 ± 0.003 |
| 0.35 | 0.00 | |
| Phase 1 (3 SNPs conditional) | 0.015 ± 0.004 | 3.26 × 10− 5 | |||||||||||
| 0.013 ± 0.004 | 1.74 × 10− 3 | ||||||||||||
| Nasal bridge depth | Phase 1 | 0.165 ± 0.062 | 8.02 × 10−3 | 0.130 ± 0.051 | 1.10 × 10− 2 | 0.33 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | 0.211 ± 0.070 | 2.50 × 10− 3 | |||||||||||
| 0.057 ± 0.091 | 5.30 × 10− 1 | ||||||||||||
| Profile nasal area | Phase 1 | 0.010 ± 0.003 | 1.33 × 10− 3 | 0.010 ± 0.003 | 8.14 × 10− 5 | 0.98 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | 0.011 ± 0.004 | 3.62 × 10− 3 | |||||||||||
| 0.010 ± 0.005 | 2.25 × 10−2 | ||||||||||||
| Nasolabial angle | Phase 1 | −0.014 ± 0.002 |
| − 0.013 ± 0.002 |
| 0.49 | 0.00 | ||||||
| Phase 1 (3 SNPs conditional) | −0.012 ± 0.003 | 7.34 × 10− 6 | |||||||||||
| − 0.011 ± 0.004 | 3.35 × 10− 3 | ||||||||||||
| Profile nasal angle | Phase 1 | − 0.007 ± 0.001 |
| − 0.006 ± 0.001 |
| 0.24 | 27.90 | ||||||
| Phase 1 (3 SNPs conditional) | −0.007 ± 0.001 |
| |||||||||||
| − 0.005 ± 0.001 | 8.53 × 10− 4 | ||||||||||||
Bold and underlined text indicates genome-wide significant P values (5 × 10− 8)
CHR chromosome, AF coded allele frequency, Q P-value for Cochrane’s Q statistic, I heterogeneity index
aPositions according to NCBI Build 36
Replication analysis of previous facial morphology GWASs
| Previously reported index SNP | Genea | Previously reported association phenotype | Reference | Tested SNP | LD (r2)b | Coded allele | Non-coded allele | Associated facial traits in Phase 1 | Association results | |
|---|---|---|---|---|---|---|---|---|---|---|
| beta ± se | ||||||||||
| rs7559271 |
| Nasion position,n-men | Adhikari, et al. [ | rs11683100 | 0.70 | G | T | Profile nasal area | 0.007 ± 0.004 | 0.043 |
| rs4648379 |
| AlrR-Prn, AlrL-Prn | Liu et al. [ | rs4648478 | 0.65 | G | A | Profile nasal angle | −0.005 ± 0.001 | 5.70 × 10− 6 |
| rs6555969 |
| ZygR-Nsn,ZygL-Nsn,EyeR-Nsn,EyeL-Nsn | Liu et al. [ | rs6555969 | 1.00 | T | C | Right palpebrale fissure length | 0.086 ± 0.069 | 0.210 |
| rs805722 |
| EyeR-Nsn,EyeL-Nsn | Liu et al. [ | rs805693 | 0.97 | T | C | Left palpebral fissure height | −0.039 ± 0.036 | 0.288 |
| rs2045323 |
| Columella inclination,Nose protrusion,Nose tip angle | Adhikari et al. [ | rs4315762 | 0.68 | G | C | Subnasal width | −0.247 ± 0.054 | 4.84 × 10−6 |
| rs1852985 |
| Nose bridge breadth | Adhikari et al. [ | rs1284964 | 1.00 | G | A | Nasal bridge angle | 0.429 ± 0.101 | 2.28 × 10−5 |
| rs2424399 |
| Nasal width | Shaffer et al. [ | rs6082475 | 1.00 | G | A | Subnasal width | 0.164 ± 0.049 | 7.28 × 10−4 |
| rs9868698 |
| PC4(facial height, nasal width) | Cole et al. [ | rs627865 | 0.98 | G | C | Subnasal width | 0.036 ± 0.051 | 0.485 |
| rs2817419 |
| EX_R_EX_L(outer canthal width) | Cole et al. [ | rs3857597 | 0.77 | T | C | Outercanthal width | 0.228 ± 0.138 | 0.098 |
| rs35965172 |
| EN_EX(Palpebral fissure length) | Cole et al. [ | rs3857597 | 0.78 | T | C | Right eyelid width | 0.011 ± 0.008 | 0.196 |
| rs7836044 |
| STO_SL(lower lip height) | Cole et al. [ | rs3850505 | 0.99 | C | T | Left upper lip thickness | −0.006 ± 0.004 | 0.163 |
| rs9456748 |
| factor 9(Facial height related to the vertical position of nasion; Nasion) | Lee et al. [ | rs6904579 | 0.86 | G | A | Facial height | −0.212 ± 0.099 | 0.033 |
| rs5781117 |
| nose size | Pickrell et al. [ | rs2605100 | 0.78 | T | C | Profile nasal angle | 0.003 ± 0.001 | 0.030 |
| rs424737 |
| nose size | Pickrell et al. [ | rs333472 | 1.00 | C | T | Nasal tip height | 0.007 ± 0.003 | 6.58 × 10−3 |
| rs2929451 |
| nose size | Pickrell et al. [ | rs2929453 | 0.94 | G | A | Nasal tip protrusion | −0.009 ± 0.007 | 0.212 |
| rs10779169 |
| nose size | Pickrell et al. [ | rs2405254 | 0.99 | T | A | Profile nasal angle | 0.003 ± 0.001 | 8.30 × 10−3 |
| rs11782517 |
| nose size | Pickrell et al. [ | rs12544801 | 0.90 | G | C | Nasolabial angle | −0.005 ± 0.003 | 0.081 |
| rs767764 |
| nose size | Pickrell et al. [ | rs2278945 | 0.71 | G | A | Nasal bridge angle | −0.307 ± 0.092 | 8.94 × 10−4 |
| rs34702092 |
| nose size | Pickrell et al. [ | rs11624333 | 1.00 | G | A | Nasal bridge angle | −0.438 ± 0.156 | 5.02 × 10−3 |
| rs6101567 |
| nose size | Pickrell et al. [ | rs6129346 | 0.99 | C | T | Frontal nasal height | −0.299 ± 0.076 | 7.53 × 10−5 |
AlrL alare left, AlrR alare right, Prn pronasale, ZygL zygion left, ZygR zygion right, Nsn nasion, EyeL eyeball left, EyeR eyeball right
aGenes are defined as previously reported
br2 is calculated based on data from phase 3 of the 1000 Genomes Project in the Asian panel (Chinese and Japanese)